Investing.com - Oric Pharma (NASDAQ: ORIC) reported second quarter EPS of $-0.50, $0.07 better than the analyst estimate of $-0.57. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Oric Pharma's stock price closed at $7.93. It is up 54.88% in the last 3 months and up 71.27% in the last 12 months.
Oric Pharma saw 3 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Oric Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Oric Pharma's Financial Health score is "fair performance".
Check out Oric Pharma's recent earnings performance, and Oric Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar